oncology market
Hypofractionation could expand radiotherapy access for 2.2 million patients
Hypofractionation could expand radiotherapy access for 2.2 million patients
Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.
China emerges as key player in oncology with antibody-drug conjugates surge
It represents 82% of the ADC pipeline in major APAC markets.
What’s driving the global gastric cancer diagnostics market?
One key trend is the integration of molecular diagnostics such as next-generation sequencing.
APAC to record fastest-growing interventional oncology market
There has been an expanding research base across India, China, and Japan.
Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Event News
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
